FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3916211000001109: Solpaflex tablets (Haleon UK Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2883251000001115 Solpaflex tablets (Haleon UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2883261000001117 Solpaflex tablets (Haleon UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Solpaflex tablets (Haleon UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 5 (CD Inv) true Inferred relationship Existential restriction modifier
Solpaflex tablets (Haleon UK Ltd) Is a Product containing precisely codeine phosphate 12.8 milligram and ibuprofen 200 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Solpaflex tablets (Haleon UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Solpaflex tablets (Haleon UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Solpaflex tablets (Haleon UK Ltd) Has active ingredient Codeine phosphate false Inferred relationship Existential restriction modifier
Solpaflex tablets (Haleon UK Ltd) Has active ingredient Ibuprofen false Inferred relationship Existential restriction modifier
Solpaflex tablets (Haleon UK Ltd) Has active ingredient Codeine false Inferred relationship Existential restriction modifier
Solpaflex tablets (Haleon UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Solpaflex tablets (Haleon UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Solpaflex tablets (Haleon UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Solpaflex tablets (Haleon UK Ltd) Is a Solpaflex true Inferred relationship Existential restriction modifier
Solpaflex tablets (Haleon UK Ltd) Has specific active ingredient Ibuprofen true Inferred relationship Existential restriction modifier
Solpaflex tablets (Haleon UK Ltd) Has specific active ingredient Codeine phosphate true Inferred relationship Existential restriction modifier
Solpaflex tablets (Haleon UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Solpaflex tablets (Haleon UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Solpaflex tablets (Haleon UK Ltd) 12 tablet Is pack of False Solpaflex tablets (Haleon UK Ltd) Inferred relationship Existential restriction modifier
Solpaflex tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets Is pack of False Solpaflex tablets (Haleon UK Ltd) Inferred relationship Existential restriction modifier
Solpaflex tablets (Haleon UK Ltd) 12 tablet Has AMP True Solpaflex tablets (Haleon UK Ltd) Inferred relationship Existential restriction modifier
Solpaflex tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets Has AMP True Solpaflex tablets (Haleon UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start